Skip to main content
. Author manuscript; available in PMC: 2022 Aug 1.
Published in final edited form as: Gynecol Oncol. 2021 Jun 2;162(2):268–276. doi: 10.1016/j.ygyno.2021.05.020

Figure 1:

Figure 1:

Overall survival for 376 patients with recurrent endometrial cancer from time of recurrence stratified by treatment modality (A) and further stratified by complete gross resection at time of SCS (B).